SCHEMBL3342745

SCHEMBL3342745

COCCn1nc(-c2ccc(C)c(C(N)=O)c2)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 1/20 0.42
KAT5 Q92993 1/20 0.42
KAT8 Q9H7Z6 1/20 0.42
MAPT P10636 1/20 0.39
HDAC3 O15379 3/20 0.38
HDAC4 P56524 3/20 0.38
HDAC1 Q13547 3/20 0.38
HDAC7 Q8WUI4 3/20 0.38
HDAC2 Q92769 3/20 0.38
HDAC10 Q969S8 3/20 0.38
HDAC11 Q96DB2 3/20 0.38
HDAC8 Q9BY41 3/20 0.38
HDAC6 Q9UBN7 3/20 0.38
HDAC9 Q9UKV0 3/20 0.38
HDAC5 Q9UQL6 3/20 0.38
NCOR2 Q9Y618 3/20 0.38
POLB P06746 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3346285 0.86 HDAC3 (0.38) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL3348300 0.85 PPARG (0.33) KAT6AKAT5KAT8MAPTHDAC3
SCHEMBL3342874 0.84 P2RX7 (0.44) MAPTPOLBMEN1KMT2ASYK
SCHEMBL3348216 0.84 P2RX7 (0.44) MAPTPOLBMEN1KMT2ASYK
SCHEMBL3342751 0.81 KATNA1 (0.38) KAT6AKAT5KAT8MAPTHDAC3
SCHEMBL3346108 0.80 P2RX7 (0.43) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL3346565 0.80 P2RX7 (0.43) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL3342797 0.80 P2RX7 (0.43) MAPTHDAC3HDAC4HDAC1HDAC7
SCHEMBL3342117 0.79 PDE4D (0.39) MAPTSYKKDM4EALDH1A1HSD17B10
SCHEMBL3342438 0.78 P2RX7 (0.46) MAPTHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 KAT6A 3948/4885KAT5 4650/4885KAT8 4693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.